Nifty and Sensex Close Higher: IndiGo, Reliance Industries in Focus

1 min read     Updated on 05 Dec 2025, 03:31 PM
scanx
Reviewed by
Shraddha JScanX News Team
Overview

Indian markets ended positive with Nifty 50 at 26,180.90 (+0.57%) and Sensex at 85,698.74 (+0.51%). Market breadth was negative with 2,636 declining stocks out of 4,512 traded. IndiGo announced customer service initiatives, Reliance Industries saw significant block trades and a credit rating upgrade, while Lupin received FDA approval for a generic drug. Apollo Micro Systems projected strong revenue growth, and Chambal Fertilisers reported increased promoter shareholding.

26474503

*this image is generated using AI for illustrative purposes only.

Market Overview

The Indian stock markets closed on a positive note, with both the Nifty 50 and BSE Sensex registering gains. The Nifty 50 ended the day at 26,180.90, up 147.15 points or 0.57% from its previous close. Similarly, the BSE Sensex closed at 85,698.74, gaining 433.42 points or 0.51%.

Market Breadth

The overall market breadth was negative, with more stocks declining than advancing:

Category Number of Scrips
Total Traded 4,512
Positive 1,876
Negative 2,636

Buzzing Stocks

Several stocks made headlines during the trading session:

IndiGo (InterGlobe Aviation Ltd)

  • Implementing multiple customer service initiatives
  • Offering food for waiting passengers and lounge access for seniors
  • Working to restart systems and schedules for improved performance
  • Received a one-time exemption from DGCA for pilot scheduling

Reliance Industries Ltd

  • Witnessed two significant block trades on NSE totaling Rs. 278.6 crores
  • S&P Global Ratings upgraded credit rating for Senior Unsecured USD Denominated Fixed Rate Notes from BBB to A- with Stable outlook

Apollo Micro Systems Ltd

  • Projects revenue growth of 45% to 50% CAGR over the next two years

Chambal Fertilisers and Chemicals Ltd

  • Promoter group increased shareholding to 962,073 equity shares (0.24% of total voting capital)

Lupin Ltd

  • Received tentative U.S. FDA approval for generic Siponimod Tablets
  • Product targets a market with estimated annual sales of USD 195 million in the U.S.

Conclusion

The Indian markets ended the day on a positive note, with both benchmark indices showing gains. However, the overall market breadth remained negative. Key stocks like IndiGo, Reliance Industries, and Lupin made significant announcements that could impact their future performance. Investors should continue to monitor these developments and their potential impact on the market.

like15
dislike
Explore Other Articles